โ€น All Posts
Kundan Motwani

13th May ยท SEBI-Registered Analyst

๐—–๐—ถ๐—ฝ๐—น๐—ฎ ๐—ค๐Ÿฐ ๐—™๐—ฌ๐Ÿฎ๐Ÿฒ ๐—ฅ๐—ฒ๐˜€๐˜‚๐—น๐˜ and price action
CIPLA

๐—–๐—ถ๐—ฝ๐—น๐—ฎ ๐—ค๐Ÿฐ ๐—™๐—ฌ๐Ÿฎ๐Ÿฒ ๐—ฅ๐—ฒ๐˜€๐˜‚๐—น๐˜ ๐—”๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ๐—ฑ ๐—ง๐—ผ๐—ฑ๐—ฎ๐˜† Cipla reported weak Q4 FY26 numbers today, but the stock showed strong buying interest after the announcement. ๐Ÿ“Œ Key Q4 FY26 Numbers: โ–ช๏ธ Net Profit: โ‚น555 Cr ๐Ÿ”ป 55% YoY โ–ช๏ธ Revenue: โ‚น6,541 Cr ๐Ÿ”ป 2.8% YoY โ–ช๏ธ EBITDA Margin: 14.6% vs 22.8% YoY โ–ช๏ธ Final Dividend Announced: โ‚น13/share ๐Ÿ“ˆ Price Action Today: โ–ช๏ธ Stock gained nearly 2%โ€“4% intraday after results โ–ช๏ธ Strong recovery from lower levels indicates positive sentiment โ–ช๏ธ Market seems to have already discounted weak earnings โ–ช๏ธ Buying seen due to strong India business growth and dividend support Technical Levels: โœ… Support Zone: โ‚น1,300โ€“1,285 โœ… Resistance Zone: โ‚น1,360โ€“1,400 โœ… Sustaining above resistance may trigger fresh momentum ๐Ÿ’ก Positive Trigger: โ€œOne Indiaโ€ business grew 15% YoY, which supported investor confidence despite weak overall profitability. โš ๏ธ Pharma sector remains stock-specific after earnings season. Traders should watch follow-up buying and volume confirmation in coming sessions.

#TechnicalViews#FundamentalViews#StockInNews#Todayโ€™sTradingSetup#EquityResearch
437 likesยท77 comments